Tri-Luma en es it fr

Tri-Luma Brand names, Tri-Luma Analogs

Tri-Luma Brand Names Mixture

  • No information avaliable

Tri-Luma Chemical_Formula


Tri-Luma RX_link

Tri-Luma fda sheet

Tri-Luma FDA

Tri-Luma msds (material safety sheet)

Tri-Luma MSDS

Tri-Luma Synthesis Reference

Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)

Tri-Luma Molecular Weight

300.435 g/mol

Tri-Luma Melting Point

181 oC

Tri-Luma H2O Solubility

<0.1 g/100 mL

Tri-Luma State


Tri-Luma LogP


Tri-Luma Dosage Forms

Capsule; Cream; Gel; Liquid

Tri-Luma Indication

For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

Tri-Luma Pharmacology

Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).

Tri-Luma Absorption

1-31% (topical);

Tri-Luma side effects and Toxicity

No information avaliable

Tri-Luma Patient Information

No information avaliable

Tri-Luma Organisms Affected

Humans and other mammals